|
According to the latest report published by Credence Research, Inc. Short Bowel Syndrome Market (Drug Type GLP-2, Glutamine, Growth Hormone and Other Drugs): Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the market was valued at US$ 315.1 Mn in 2016, and is expected...
|
|
|
|
|